Cancer Deaths Drop: 33% Decline & 4 Million Lives Saved
Boosted cancer survival rates signal a new era of hope: A 33% decline in cancer deaths since the 1970s translates to millions more lives saved. The change stems from breakthroughs in cancer treatment, prevention, and early detection. From acute lymphoblastic leukemia, where survival rates have soared past 90%, to the impact of HPV vaccines on cervical cancer, the data reveals powerful progress. Screening advancements and therapies like CAR-T are also at the forefront of this revolution. News Directory 3 is following the latest developments, sharing critical insights into these advances and the ongoing fight. Discover what’s next in the quest for even greater breakthroughs and improved patient outcomes.
Cancer survival rates climb thanks to vaccines, screening, treatment
Updated June 07, 2025
Significant strides in cancer treatment and prevention have dramatically improved survival rates, offering new hope to patients. Once dire diagnoses are now increasingly manageable, thanks to advances in vaccines, screening and innovative therapies.
the progress is evident across various cancers. For instance, the five-year survival rate for acute lymphoblastic leukemia in children has soared from approximately 10% to over 90%. the five-year survival rate for all cancers has risen from 49% in the mid-1970s to 69% as of 2019.
Jon Gluck, diagnosed with multiple myeloma, a blood and bone marrow cancer, in 2003, was initially given only 18 months to live. At the time, the five-year survival rate for myeloma was just 34%. Today,it has nearly doubled to 62%,with many patients living much longer. “There has been a revolution in cancer survival,” Gluck said.
Anti-smoking policies have played a crucial role in reducing cancer risk, but other interventions have also proven effective.the HPV vaccine, for example, has led to a 62% drop in cervical cancer deaths among U.S. women ages 20–39 between 2012 and 2021, according to a recent study. Vaccination can have positive effects on reducing cancer incidence.
Early and improved screening methods also contribute to better outcomes. the earlier cancer is detected, the higher the likelihood of survival. From 2000 to 2010, late-stage colorectal cancer cases in Americans over 50 decreased by a third, largely due to increased colonoscopy rates. Newer screening technologies, including AI and blood-based tests, promise simpler and more accessible preliminary screenings.
Breakthroughs in cancer treatment,such as lenalidomide and bortezomib,have doubled median myeloma survival rates. Monoclonal antibodies have also significantly extended patients’ lives. CAR-T therapy, a form of immunotherapy that turns a patient’s own T-cells into guided missiles, is especially promising. A recent study showed that a third of multiple myeloma patients, many facing hospice care, experienced no detectable cancer five years after receiving CAR-T therapy.
“CAR-T is mind-blowing — very science-fiction futuristic,” Gluck said, who underwent the treatment in mid-2023. He added that the experience, which put his cancer into remission, left him feeling “physically and metaphysically new.”
Despite these advancements,challenges remain,including rising rates of gastrointestinal cancers among younger people. However, the future of cancer treatment continues to improve, offering new hope and extended lives for patients.
What’s next
Ongoing research and progress in cancer therapies promise further improvements in survival rates and quality of life for patients. While uncertainty remains a part of living with cancer, the progress made offers a more optimistic outlook than ever before.